U.S. market Closed. Opens in 11 hours 48 minutes

NUVB | Nuvation Bio Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue222.00K484.00K368.00K103.00KN/A
Gross Profit-222.00K-484.00K-368.00K-103.00KN/A
Operating Expenses99.60M119.73M93.32M43.55M32.18M
Selling, General & Admin28.31M31.92M24.28M10.95M6.99M
Research & Development71.29M87.81M69.04M32.60M25.11M
Other Operating ExpensesN/A-872.00K-644.00K-271.00KN/A
Operating Income-99.82M-119.73M-93.32M-43.55M-32.10M
Other Expenses / Income24.02M15.54M6.47M1.89M-1.45M
Before Tax Income-75.80M-104.20M-86.85M-41.66M-33.55M
Income Tax ExpensesN/A-15.54M-7.11M-2.16MN/A
Net Income-75.80M-88.66M-79.73M-39.50M-33.55M
Interest ExpensesN/A-9.16MN/AN/AN/A
Basic Shares Outstanding218.88M216.72M197.89M97.53M206.67M
Diluted Shares Outstanding218.88M216.72M197.89M97.53M206.67M
EBITDA-99.60M-128.69M-97.28M-43.67M-32.09M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-75.80M-113.36M-86.85M-41.66M-33.55M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙